DioGenix's Series C Round

DioGenix raised a round of funding on December 05, 2013. Investors include Nerveda.

DioGenix is developing molecular tests using application-specific, high-resolution technologies that measure well-established human biology. With a focus in immune-mediated neurological diseases and d…

Articles about DioGenix's Series C Round: